We are proud to announce, Jim Keith, CSO of EmstoPA as Keynote Speaker at the Virtual Precision in Drug Discovery & Preclinical Summit on Thursday, July 23rd. He will be discussing “Exploring EmstoPA-The First Specific Treatment for tPA-Induced Bleeding”

A new report from GlobalData shows that the stroke market is about to experience growth across the eight major markets as a result of increasing population, especially in China.


CEO, Charles Phillips, will be at #bioeurope next week. Reach out to us if you’d like a meeting to discuss EmstoPA, the novel tpa antidote.

The EmstoPA team had a great time at #RESIBOS17. If you missed us there, visit http://www.emstopa.com to find out more!

Stroke deaths are on the rise, at the rate of 4% per year, according to a new report from the CDC – https://goo.gl/3np4YA

Load More…

Increasing Population Will Drive the Growth of the Acute Stroke Market

According to a newly released report from GlobalData Healthcare, The acute ischemic stroke (AIS) market is about to experience growth across the eight major markets (the 8MM: US, France, Germany, Italy,…
Read More
After more than four decades of decline, progress has slowed in preventing stroke deaths, according to a report in a recent issue of Vital Signs (https://www.cdc.gov/vitalsigns/) by the Centers for…
Read More

Incidents Of Stroke Predicted To Rise By 59% In Next 20 Years

There will be a 59% rise in the number of people suffering a stroke over the next 20 years, a new report suggests. High blood pressure, which is linked to…
Read More

Rural America stroke incidents on the rise.

  This is an interesting article pointing to a 30% higher incidence of stroke and a resulting 30% higher mortality rate following stroke in rural America. This could be because of…
Read More